Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

Sep 2021| TBR520E| TBRC (Publisher)

Report Highlights

Including: 1) By Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs
2) By End User: Asthma Patients; COPD Patients
3) By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers
4) By Age Group: Below 5 Years; 5 To 14 Years; 15-60 Years; Above 60 Years
5) By Therapy: Preventive; Curative
6) By Route Of Administration: Inhaled; Intravenous; Subcutaneous; Oral
7) By Prescription: Prescription; OTC
8) By Drug Type: Branded; Generics
Covering: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer-Ingelheim GmbH; F. Hoffmann-La Roche Ltd; Novartis AG

Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest growing market for anti-asthmatics and COPD drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-asthmatics and COPD drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider anti-asthmatics and COPD drugs market, and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by drug class, segmentation by end-user, segmentation by distribution channel, segmentation by therapy, segmentation by route of administration, segmentation by age group, segmentation by prescription and segmentation by drug type.
  • Market Characteristics – The market characteristics section of the report defines and explains the anti-asthmatics and COPD drugs market. This chapter also defines and describes products and related services covered in the report.
  • Supply Chain –The supply chain section of the report defines and explains the key players in the anti-asthmatics and COPD drugs industry supply chain.
  • Product Analysis –The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Top 10 Leading Drugs Sales –The section describes list of top 10 drugs and their sales in the anti-asthmatics and COPD drug market in 2020. It briefs on the drug chemical composition, drug class and the manufacturers involved in manufacturing and selling of these leading drugs in the anti-asthmatics and COPD drugs market.
  • Patent Analysis Of Leading Drugs –The section briefs on the patent analysis of the leading drugs in the anti-asthmatics and COPD drugs market, by focusing on the leading drugs’ patent expiry and emergence of the generic drugs in the market.
  • Customer Information – This chapter covers recent customers’ trends/preferences in the global anti-asthmatics and COPD drugs market.
  • Impact Of COVID-19 – This section describes the impact of COVID-19 on the anti-asthmatics and COPD drugs market.
  • Regulatory Landscape – This section describes the regulatory bodies and regulations on the anti-asthmatics and COPD drugs market.
  • Trends And Strategies – This chapter describes the major trends shaping the global anti-asthmatics and COPD drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Asthma And COPD Prevalence Overview–This section describes about asthma and COPD and their prevalence in the major countries.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison – The global anti-asthmatics and COPD drugs market comparison with macro-economic factors gives the anti-asthmatics and COPD drugs market size, percentage of GDP, and average anti-asthmatics and COPD drugs market expenditure.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global anti-asthmatics and COPD drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background – This section describes the respiratory diseases drugs market of which the anti-asthmatics and COPD drugs market is a segment. This chapter includes the respiratory diseases drugs market 2015-23 values, and regional analyses for the respiratory diseases drugs market.
  • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-asthmatics and COPD drugs providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • By Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs
  • By End User: Asthma Patients; COPD Patients
  • By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers
  • By Age Group: Below 5 Years; 5 To 14 Years; 15-60 Years; Above 60 Years
  • By Therapy: Preventive; Curative
  • By Route Of Administration: Inhaled; Intravenous; Subcutaneous; Oral
  • By Prescription: Prescription; OTC
  • By Drug Type: Branded; Generics

Companies Mentioned: GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer-Ingelheim GmbH; F. Hoffmann-La Roche Ltd; Novartis AG

Metrics Covered: Number of Enterprises; Number of Employees; Per Capita Expenditure

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; UK; Germany; France; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; Anti-Asthmatics And COPD Drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
  • Table 2 : Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2020
  • Table 3 : Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2020
  • Table 4 : Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
  • Table 5 : Prevalence Of Asthma, 2015-2019
  • Table 6 : Prevalence Of COPD, 2015-2019
  • Table 7 : Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 8 : Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 9 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 14 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 15 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 16 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 17 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 18 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 19 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
  • Table 20 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
  • Table 21 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
  • Table 22 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
  • Table 23 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
  • Table 24 : Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 25 : Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 26 : Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 27 : Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 28 : Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 29 : Air Pollution And Air Quality Index, Asia-Pacific Countries
  • Table 30 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 31 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36 : China GDP Per Capita, 2015-2020, $
  • Table 37 : China, Population By Age Group, 2015-2023, Thousands
  • Table 38 : China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 39 : China Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 40 : China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 41 : China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 42 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 43 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 44 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 45 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
  • Table 46 : India GDP Per Capita, 2015-2020, $
  • Table 47 : India, Population By Age Group, 2015-2023, Thousands
  • Table 48 : India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 49 : India Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 50 : India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 51 : India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 52 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 53 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 54 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 55 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 56 : Japan GDP Per Capita, 2015-2020, $
  • Table 57 : Japan, Population By Age Group, 2015-2023, Thousands
  • Table 58 : Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 59 : Japan Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 60 : Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 61 : Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 62 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 63 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 64 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 65 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 66 : Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 67 : Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 68 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 69 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 70 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 71 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 72 : Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 73 : Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 77 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 78 : South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 79 : South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 80 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 81 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 82 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 83 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 84 : Western Europe GDP Per Capita, 2015-2020, $
  • Table 85 : Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 86 : Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 87 : Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 88 : Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 89 : Air Pollution And Air Quality Index in 2018, Western Europe Countries
  • Table 90 : Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 91 : Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 92 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 93 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 94 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 95 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 96 : UK GDP Per Capita, 2015-2020, $
  • Table 97 : UK, Population By Age Group, 2015-2023, Thousands
  • Table 98 : UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 99 : UK Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 100 : UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 101 : UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 102 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 103 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 104 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 105 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 106 : Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 107 : Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 108 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 109 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 110 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112 : France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 113 : France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 114 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 115 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 116 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 117 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 118 : Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 119 : Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 120 : Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 121 : Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 122 : Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 123 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 124 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 125 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 126 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 127 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 128 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 129 : Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 130 : Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 131 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 134 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 135 : North America GDP Per Capita, 2015-2020, $
  • Table 136 : North America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 137 : North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 138 : North America Private Healthcare Expenditure, 2013-2017, $ Billion
  • Table 139 : North America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 140 : North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 141 : North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 142 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 143 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 144 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 145 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 146 : USA GDP Per Capita, 2015-2020, $
  • Table 147 : USA, Population By Age Group, 2015-2023, Thousands
  • Table 148 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 149 : USA Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 150 : USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 151 : USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 152 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 153 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 154 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 155 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 156 : South America GDP Per Capita, 2015-2020, $
  • Table 157 : South America, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 158 : South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 159 : South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 160 : South America Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 161 : South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 162 : South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 163 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 164 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 165 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 166 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 167 : Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 168 : Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 169 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 170 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 171 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 172 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 173 : Middle East GDP Per Capita, 2015-2020, $
  • Table 174 : Middle East, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 175 : Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 176 : Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 177 : Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 178 : Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 179 : Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 180 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 181 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 182 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 183 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 184 : Africa GDP Per Capita, 2015-2020, $
  • Table 185 : Africa, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 186 : Africa Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 187 : Africa Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 188 : Africa Total Population Aged 65 And Above, 2015-2023, Thousands
  • Table 189 : Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 190 : Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 191 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 192 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 193 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 194 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 195 : Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 196 : GlaxoSmithKline – Financial Overview, 2016 - 2020, $ Billion
  • Table 197 : AstraZeneca plc. – Financial Overview, 2016 - 2020, $ Billion
  • Table 198 : Boehringer Ingelheim GmbH – Financial Overview, 2016 - 2020, $ Billion
  • Table 199 : F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
  • Table 200 : Novartis AG – Financial Overview, 2016 - 2020, $ Billion
  • Table 201 : Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Table 202 : Global Respiratory Diseases Drugs Market, 2020, Split By Region
  • Table 203 : Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 204 : Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 205 : Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Drug Class, 2020 – 2025
  • Table 206 : Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By End Users, 2020 – 2025
  • Table 207 : Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
  • Table 208 : Anti-Asthmatics And COPD Drugs - Market Data Sources
  • Figure 1 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
  • Figure 2 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
  • Figure 3 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
  • Figure 4 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
  • Figure 5 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
  • Figure 6 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
  • Figure 7 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
  • Figure 8 : Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
  • Figure 9 : Market Supply Chain For Anti-Asthmatics And COPD Drugs
  • Figure 10 : Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 11 : Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 12 : Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13 : Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
  • Figure 18 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
  • Figure 19 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
  • Figure 20 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
  • Figure 21 : Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
  • Figure 22 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 23 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 24 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 25 : Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26 : China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 27 : China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29 : China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30 : India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 31 : India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 32 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 33 : India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34 : Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 35 : Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 36 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37 : Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 38 : Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 39 : Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 40 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 41 : Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 42 : Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 43 : Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 44 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 45 : Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46 : South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 47 : South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49 : South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 50 : Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 51 : Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 52 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 53 : Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54 : UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 55 : UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 56 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 57 : UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58 : Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 59 : Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 60 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 61 : Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 62 : France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 63 : France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 64 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 65 : France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 66 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 67 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 68 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 69 : Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 70 : Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 71 : Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 72 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 73 : Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74 : North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 75 : North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 76 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 77 : North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 78 : USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 79 : USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 80 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 81 : USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82 : South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 83 : South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 84 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 85 : South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 86 : Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 87 : Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 88 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 89 : Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 90 : Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 91 : Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 92 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 93 : Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94 : Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 95 : Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 96 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 97 : Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 98 : Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 99 : GlaxoSmithKline – Financial Overview, 2016 – 2020, $ Billion
  • Figure 100 : AstraZeneca plc. – Financial Overview 2016 – 2020, $ Billion
  • Figure 101 : Boehringer Ingelheim GmbH – Financial Overview, 2016 – 2020, $ Billion
  • Figure 102 : F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
  • Figure 103 : Novartis AG – Financial Overview, 2016 – 2020, $ Billion
  • Figure 104 : Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
  • Figure 105 : Global Respiratory Diseases Drugs Market, 2020, Split By Region
  • Figure 106 : Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report